December, 05th | 14:24 - 14:27
Intraocular Pressure Outcomes with Intravitreal Aflibercept 8 mg and 2 mg in Patients with Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Phase 3 trials
LANZETTA PAOLO
Full program
Add to calendar